Exploring the solid form landscape of the antifungal drug isavuconazole: crystal structure analysis, phase transformation behavior and dissolution performance
- 18 November 2021
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 23 (48) , 8513-8526
Abstract
Isavuconazole (ISV) is a systemic antifungal agent and is used to treat invasive aspergillosis, mucormycosis and candidiasis. Although both oral and intravenous dosage forms of this drug exist on the market, the crystal structure and physicochemical properties of ISV as well as possible alternative solid forms are yet unexplored in the literature. In the present work, the solid form landscape of isavuconazole including solvate, polymorph and salt screening was studied systematically. The solid-state properties of the initial crystalline ISV and newly obtained forms (ISV monohydrate, two amorphous forms obtained by different means and two pharmaceutical salts with p-toluenesulfonic acid and phosphoric acid) were described for the first time. The structures of all crystalline forms were solved based on single crystal X-ray diffraction data, and the packing forces in the considered solids were studied using different theoretical approaches. The transformation pathways between the ISV solid forms were investigated experimentally and rationalized based on DFT computations and non-covalent interaction analysis. It was observed that crystalline isavuconazole does not transform into the hydrate upon dissolution, in contrast to other solid forms. The amorphous and salt forms of ISV were found to demonstrate a spring-like increase of the drug concentration in pharmaceutically relevant buffer media. The tableting of the pharmaceutical salts leads to slower phase transformation into the ISV hydrate and prolonged drug supersaturation.Keywords
Funding Information
- National Natural Science Foundation of China (19-13-00017)
This publication has 72 references indexed in Scilit:
- Cl···Cl Interactions in Molecular Crystals: Insights from the Theoretical Charge Density AnalysisThe Journal of Physical Chemistry A, 2013
- Noncovalent Interactions in Crystalline Picolinic Acid N-Oxide: Insights from Experimental and Theoretical Charge Density AnalysisCrystal Growth & Design, 2013
- Crystal Polymorphism in Chemical Process DevelopmentAnnual Review of Chemical and Biomolecular Engineering, 2011
- Efficient computer modeling of organic materials. The atom–atom, Coulomb–London–Pauli (AA-CLP) model for intermolecular electrostatic-polarization, dispersion and repulsion energiesNew Journal of Chemistry, 2011
- Modifying the Diffusion Layer of Soluble Salts of Poorly Soluble Basic Drugs To Improve Dissolution PerformanceMolecular Pharmaceutics, 2010
- A consistent and accurateab initioparametrization of density functional dispersion correction (DFT-D) for the 94 elements H-PuThe Journal of Chemical Physics, 2010
- Polymorph control: past, present and futureDrug Discovery Today, 2008
- A new class of proton-conducting ionic plastic crystals based on organic cations and dihydrogen phosphateElectrochemistry Communications, 2007
- Development of a pharmaceutical cocrystal of a monophosphate salt with phosphoric acidChemical Communications, 2006
- Crystal field effects on the topological properties of the electron density in molecular crystals: The case of ureaThe Journal of Chemical Physics, 1994